These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29123987)

  • 1. Jun dimerization protein 2 controls hypoxia-induced replicative senescence via both the p16
    Nakade K; Lin CS; Chen XY; Tsai MH; Wuputra K; Zhu ZW; Pan JZ; Yokoyama KK
    FEBS Open Bio; 2017 Nov; 7(11):1793-1804. PubMed ID: 29123987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JDP2 (Jun Dimerization Protein 2)-deficient mouse embryonic fibroblasts are resistant to replicative senescence.
    Nakade K; Pan J; Yamasaki T; Murata T; Wasylyk B; Yokoyama KK
    J Biol Chem; 2009 Apr; 284(16):10808-17. PubMed ID: 19233846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone chaperone Jun dimerization protein 2 (JDP2): role in cellular senescence and aging.
    Huang YC; Saito S; Yokoyama KK
    Kaohsiung J Med Sci; 2010 Oct; 26(10):515-31. PubMed ID: 20950777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Jun dimerization protein 2 in oxygen restriction; control of senescence.
    Wang SW; Lee JK; Ku CC; Chiou SS; Steve Lin CL; Ho MF; Wu DC; Yokoyama KK
    Curr Pharm Des; 2011; 17(22):2278-89. PubMed ID: 21736542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Jun dimerization protein 2 controls senescence and differentiation via regulating histone modification.
    Huang YC; Hasegawa H; Wang SW; Ku CC; Lin YC; Chiou SS; Hou MF; Wu DC; Tsai EM; Saito S; Yamaguchi N; Yokoyama KK
    J Biomed Biotechnol; 2011; 2011():569034. PubMed ID: 21197464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation of p16Ink4a and Arf by JDP2 in cellular senescence.
    Nakade K; Wasylyk B; Yokoyama KK
    Biomol Concepts; 2010 May; 1(1):49-58. PubMed ID: 25961985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
    Shin J; Yang J; Lee JC; Baek KH
    Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma.
    Tannapfel A; Sommerer F; Benicke M; Weinans L; Katalinic A; Geissler F; Uhlmann D; Hauss J; Wittekind C
    J Pathol; 2002 Aug; 197(5):624-31. PubMed ID: 12210082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
    D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
    Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of the INK4a-ARF gene locus in pleomorphic adenoma of the parotid gland.
    Weber A; Langhanki L; Schütz A; Wittekind C; Bootz F; Tannapfel A
    J Pathol; 2002 Nov; 198(3):326-34. PubMed ID: 12375265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase inhibitors induce a senescence-like state in human cells by a p16-dependent mechanism that is independent of a mitotic clock.
    Munro J; Barr NI; Ireland H; Morrison V; Parkinson EK
    Exp Cell Res; 2004 May; 295(2):525-38. PubMed ID: 15093749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ndy1/KDM2B immortalizes mouse embryonic fibroblasts by repressing the Ink4a/Arf locus.
    Tzatsos A; Pfau R; Kampranis SC; Tsichlis PN
    Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2641-6. PubMed ID: 19202064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic alterations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma.
    Peng CY; Chen TC; Hung SP; Chen MF; Yeh CT; Tsai SL; Chu CM; Liaw YF
    Anticancer Res; 2002; 22(2B):1265-71. PubMed ID: 12168936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
    D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG
    Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MOZ (MYST3, KAT6A) inhibits senescence via the INK4A-ARF pathway.
    Sheikh BN; Phipson B; El-Saafin F; Vanyai HK; Downer NL; Bird MJ; Kueh AJ; May RE; Smyth GK; Voss AK; Thomas T
    Oncogene; 2015 Nov; 34(47):5807-20. PubMed ID: 25772242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of p19(Arf) and p16(Ink4a) loss on senescence of murine bone marrow-derived preB cells and macrophages.
    Randle DH; Zindy F; Sherr CJ; Roussel MF
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9654-9. PubMed ID: 11481442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H3K9me-enhanced DNA hypermethylation of the p16INK4a gene: an epigenetic signature for spontaneous transformation of rat mesenchymal stem cells.
    Zheng Y; He L; Wan Y; Song J
    Stem Cells Dev; 2013 Jan; 22(2):256-67. PubMed ID: 22873822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p16(Ink4a) in melanocyte senescence and differentiation.
    Sviderskaya EV; Hill SP; Evans-Whipp TJ; Chin L; Orlow SJ; Easty DJ; Cheong SC; Beach D; DePinho RA; Bennett DC
    J Natl Cancer Inst; 2002 Mar; 94(6):446-54. PubMed ID: 11904317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One INK4 gene and no ARF at the Fugu equivalent of the human INK4A/ARF/INK4B tumour suppressor locus.
    Gilley J; Fried M
    Oncogene; 2001 Nov; 20(50):7447-52. PubMed ID: 11704876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma.
    Edmunds SC; Kelsell DP; Hungerford JL; Cree IA
    Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2845-51. PubMed ID: 12202501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.